Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Clinical trial NCT06730581 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06730581
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Adenocarcinoma Metastatic Ovarian Cancer Bile Duct Cancer

Start date: 2024-12-01
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.